Key Financial Data Of Group

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7340635

Concept As at
2024-03-31
2024-01-01 to
2024-03-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-03-31
As at
2023-03-31
Key financial data of group
Business results of group
Revenue
236,949,000,000 JPY
1,111,367,000,000 JPY
312,240,000,000 JPY
Profit (loss) before tax
99,889,000,000 JPY
443,821,000,000 JPY
99,662,000,000 JPY
Profit (loss)
74,401,000,000 JPY
325,472,000,000 JPY
73,500,000,000 JPY
Profit (loss), attributable to owners of parent
74,401,000,000 JPY
325,472,000,000 JPY
73,500,000,000 JPY
Comprehensive income
82,114,000,000 JPY
332,256,000,000 JPY
78,149,000,000 JPY
Comprehensive income, attributable to owners of parent
82,114,000,000 JPY
332,256,000,000 JPY
78,149,000,000 JPY
Total assets
1,897,764,000,000 JPY
1,932,547,000,000 JPY
1,771,973,000,000 JPY
Basic earnings (loss) per share
45.22
197.83
44.68
Diluted earnings (loss) per share
45.21
197.80
44.67
Ratio of owners' equity to gross assets
0.865 xbrli:pure
0.841 xbrli:pure
0.811 xbrli:pure
Cash flows from (used in) operating activities
100,913,000,000 JPY
409,925,000,000 JPY
127,748,000,000 JPY
Cash flows from (used in) investing activities
-32,244,000,000 JPY
-37,290,000,000 JPY
-35,371,000,000 JPY
Cash flows from (used in) financing activities
-66,872,000,000 JPY
-139,331,000,000 JPY
-67,281,000,000 JPY
Cash and cash equivalents
462,863,000,000 JPY
458,674,000,000 JPY
247,686,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.